Pancreatic ductal adenocarcinoma (PDAC) subtyping typically relies on immunohistochemistry (IHC) staining for critical markers like HNF1A and KRT81, a labor‐intensive manual staining process that introduces variability. The gene discussed is KRT81; the disease is pancreatic ductal adenocarcinoma.